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Throughout this document, we use “antibiotics” as opposed to “antimicrobials.” The former term
is commonly used, including by the Centers for Disease Control and Prevention1, to refer to
antimicrobial agents used to treat bacterial infections in both people and animals.

Executive Summary
Antibiotic resistance – as governments,2 leading
medical3 and public health organizations around
the world now agree4,5 – is one of the most serious
public health crises today.
Before the discovery of antibiotics, patients with
routine bacterial infections often died. Without
urgent action, that reality is likely to return as
infections that are no longer treatable with today’s
antibiotics continue to increase. At the same
time, new antibiotics are proving challenging to
develop.6 Over the last several decades, only two
new classes of antibiotics have been developed and
brought to market.7,8 Additionally, doubts have
been raised about whether laws recently passed
by the U.S. Congress granting financial rewards to
pharmaceutical companies will actually help bring
antibiotics to market that are both novel and more
effective than existing drugs.9,10 Even if development
work on new medicines were to begin today and
eventually succeed, experience suggests that their
availability for treating patients would be at least a
decade away.
Antibiotic use in people and in food animal
production are important drivers of antibiotic
resistance.11,12,13,14,15,16 The World Health
Organization (WHO)17, United Nations18, European
Medicines Agency19, and the Centers for Disease
Control and Prevention (CDC)20 agree on the
need to optimize use of antibiotics in both people
and animals. Until we become better stewards of
antibiotics, both in human medicine and in livestock
production, these life-saving drugs will continue
to become less effective, and the effectiveness of
any antibiotics developed in the future will be at
constant risk.

The 2015 U.S. National Action Plan to Combat
Antibiotic-Resistant Bacteria (CARB) focuses on
curbing inappropriate antibiotic use in hospitals and
clinic settings and has measurable reduction goals.
However, the plan to curtail antibiotic use in food
animal production is narrower in scope, mainly
addressing the limited phase-out of antibiotics
in animal feed or water for growth promotion
purposes. This is problematic given that about 70%
of medically important antibiotics21 sold in the U.S.
(i.e. those identical or belonging to the same class
as antibiotics used in human medicine) are sold
for use in food-producing animals, not people.22
Furthermore, the U.S. ranks second globally among
users of antibiotics in food animal production,
accounting for roughly 13% of the world’s total.23
The imperative of this Commission is to keep
existing antibiotics working and effective for as
long as possible. We came together, as antibiotic
resistance experts from the fields of infectious
diseases, microbiology, veterinary and human
medicine, to craft this Roadmap for how U.S. policy
can and should better address the contribution
to antibiotic resistance from antibiotic use in
food animal production. We make specific policy
recommendations in three key areas: decreasing
antibiotic use, monitoring antibiotic use, and
surveilling antibiotic resistance.
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Summary of Roadmap Recommendations*
A. Decreasing Livestock Use of Medically Important Antibiotics
1. Set targets for reducing antibiotic use.
2. Phase out routine or programed use of medically important antibiotics.
3. Reduce the need for antibiotics by adopting non-antibiotic best practices, and by innovating
new technologies, to maintain animal health and prevent disease.
4. Eliminate antibiotic use where efficacy can no longer be demonstrated.
5. Prioritize the use in veterinary practice of antibiotics that the WHO does not categorize as
“critically important” for human medicine, such that:
		A. Antibiotics in the “Critically important” category are only used to treat animals
		
sick with a specific bacterial disease. Use of the subset of critically important 		
		
antibiotics the WHO refers to as “highest priority” also should require testing that
		
confirms the bacterium involved is not susceptible to other antibiotics.
		B. Do not approve for food and animal use any “critically important” antibiotics,
		
such as carbapenems, that are not currently FDA-approved for this purpose;
6. Bolster veterinary oversight of antibiotic use with other safeguards.
B. Monitoring Antibiotic Use to Reduce Antibiotic Resistance
7. Develop a system for collecting detailed, comprehensive data on actual antibiotic use, 		
and collect essential data.
8. Coordinate with and learn from the other countries in developing a comprehensive 		
data collection system.
9. Adopt a metric for reporting data on antibiotic sales or use that better allows trends to 		
be identified, explained and compared.
C. Enhancing Surveillance and Data Integration to Inform Antibiotic Use Policy
10. Integrate available data into a single, comprehensive report.
11. Improve surveillance to detect new and emerging resistance threats.
		A. Expand surveillance for emerging resistance using next generation sequencing
		
technology.
		B. Expand surveillance for important emerging pathogens,
		C. Pilot test approaches that comprehensively detect resistance in all bacteria in a
		
sample.
		D. Expand surveillance at the state level.

* Note: The numbering of the recommendations is not meant to connote any particular prioritization.
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The following report fleshes out these recommendations and the rationale for each.
Many of the recommendations draw upon successful models already implemented in
Denmark and the Netherlands, two European countries with robust livestock sectors,
comparable in size to that found in some of the most important livestock-producing
states in the U.S. Antibiotic use in food animal production in both countries has been
markedly reduced, and has been generally accompanied by lowered or plateaued levels
24 25 26
of resistant bacteria on animals and in meat, and sometimes in human populations.
27 28 29 30
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The Antibiotic Resistance Threat And Its Context
For a rising number of life-threatening infections, we have almost run out of safe,
dependable and effective antibiotics that will treat them.31,32 The CDC conservatively
estimates that 23,000 Americans die each year of antibiotic-resistant infections.33 Actual
deaths, some experts say, may be four times higher.34 Predictions are that the global toll
from a select number of resistant infections, estimated currently at 700,000 deaths per
year, will rise to 10 million annually by 2050, surpassing deaths from cancer.35
Many of the 2 million Americans who suffer from antibiotic-resistant infections each
year have prolonged illness. Even recovered patients can be left disabled, disfigured or
with permanent pain. Beyond its human costs, the antibiotic resistance epidemic poses
an emerging threat to national and economic security. 36 Drug-resistant infections are
estimated to cost more than $55 billion each year in extra U.S. medical costs (because
of use of more expensive antibiotics, and longer and more intensive hospitalizations)
and lost productivity.37
Doctors often recommend procedures that can be complicated by infections, including
joint replacements and chemotherapy, dialysis and Cesarean delivery, confident
that there will be an antibiotic available if needed. Raising poultry, pigs and cattle
successfully also depends on having antibiotics that work on sick animals. But this
reliance on what are now the cornerstones of modern medicine could be in jeopardy.
Without stronger action today, physicians and veterinarians face a future with less
effective antibiotics, where their treatment of patients and animals may need to be
substantially reconsidered.
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Why This Roadmap Focuses on
Medically Important Antibiotic Use in
Agriculture
Antibiotics are often necessary to treat sick patients
and animals. But all uses of antibiotics even the
most prudent can contribute to resistance. More
specifically, exposing bacteria to antibiotics can
spur resistance to emerge, be selected for, and then
spread; that’s as true for bacteria in animals as it
is for bacteria in people.38 The solution is not to
avoid using antibiotics completely but rather to use
them appropriately and only when necessary as
the discoverer of the first antibiotic (penicillin), Sir
Alexander Fleming, acknowledged more than seven
decades ago.39
This Commission believes the antibiotic resistance
crisis cannot be resolved by only addressing
antibiotic use in people, given the extensive use
of the drugs in food animal production. As the
CDC stated unequivocally in 2013: “Scientists
around the world have provided strong evidence
that antibiotic use in food producing animals can
harm public health....”40 Poultry and livestock
production accounts for about 70% of the medically
important antibiotics (i.e. those in the same classes
of antibiotics as those used in human medicine)
sold in the U.S.41 In 2015, the latest year for
which data are publicly available, this translates
to 21,389,200 pounds of medically important
antibiotic active ingredient sold for use in foodproducing animals.42,43 These include critically
important antibiotics that the WHO considers to
be the highest priority for human medicine, such
as macrolides, fluoroquinolones and 3rd generation
cephalosporins. Compared to the rest of the
developed world, as we later discuss, the U.S. is
among the most intensive users of antibiotics in
food animal production.Yet, as we discuss further,
the U.S. National Action Plan for Combating
Antibiotic-Resistant Bacteria (CARB) proposes

inappropriate antibiotic use in human medicine, but
fails to set equivalent, numeric goals for reducing
antibiotics used in food animal production.44

A One Health Perspective
Experts agree that the 21st century crisis of
antibiotic resistance is a “One Health” issue.45,46 One
Health is a public health concept recognizing that
the health of people, animals and the environments
in which they co-exist ‒ including the bacterial
ecosystem are interconnected.47,48 Underscoring the
importance of a One Health approach is the fact
that scientists estimate “6 out of every 10 infectious
diseases in people are spread from animals49”, as
well as a recent study suggesting that at least some
outbreaks of “livestock-associated” MRSA may
stem from an initial introduction of that MRSA
from people onto farms.50 The Danish Integrated
Antimicrobial Resistance Monitoring and Research
Programme (DANMAP) reiterates this approach:
“DANMAP was developed making the most of a
collaborative spirit between stakeholders and with a
common understanding of [antimicrobial resistance]
as a serious health threat requiring a One Health
approach to counter - because humans, foods
and animals constitute overlapping reservoirs of
antimicrobial resistance.”
One Health also describes a more integrated,
interdisciplinary approach to tackling infectious
disease threats to global health, involving
microbiologists, ecologists and epidemiologists,
physicians and veterinarians. This Commission
has taken a One Health approach as reflected
by its make-up, as well as in its conclusions and
recommendations. A One Health understanding
underlies our shared sense that the antibiotic
resistance crisis, whether in animal or human
settings, is largely a “numbers game” the higher the
use, the more resistance can emerge and spread ‒
which Box A explains in greater detail.

concrete and measurable goals for curbing
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A half century of science, and hundreds of individual studies and reviews, support the idea that
antibiotic resistance is a numbers game; in short, the risk for emergence and enrichment of
antibiotic-resistant bacteria goes up with each person or animal that is treated or exposed to those
drugs.51,52,53,54,55,56 Many scientific reviews, by renowned experts, have concluded that the existing
body of evidence justifies stronger action to reduce antibiotic use in both human and animal
settings. 57,58,59, 60,61,62 Our goal was not to duplicate these reviews, but instead to generate consensus
recommendations, based upon the existing body of science, for policies and practices that will help
curtail the unnecessary use of antibiotics in food animal production.

Box A: One Health: Factors That Can Contribute to the Spread of Antibiotic Resistance
–
The greater the quantity of antibiotics used, the more resistance will emerge and
spread.63,64,65
The greater the number of individuals (human or animal) that are given antibiotics,
the more bacteria are exposed, and the greater the likelihood resistance will emerge
and spread.66,67
The longer the duration of antibiotic use, the longer the period of time over which
resistance can emerge and spread.68,69,70,71
Editorial Note from the Commission:While exceptions may exist, these observations around
antibiotic use and its impact on resistance hold true more often than not.
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Roadmap Recommendations for U.S. Policy
on Use of Medically Important Antibiotics in
Food Production
In March 2015, the Obama Administration released the National Action Plan to
Combat Antibiotic-Resistant Bacteria (CARB).72 It was presented as a guiding
document to coordinate and map federal efforts to address antibiotic resistance, and
ultimately preserve the future efficacy of antibiotics.
CARB establishes five national goals to better understand, track and reduce antibiotic
use, each of them accompanied by milestones and outcomes to be achieved by 2020.
However, comprehensive goals and milestones to better track, understand and reduce
antibiotic use in human settings are not mirrored by similarly comprehensive goals
around antibiotic use in the production of livestock and poultry. Regarding antibiotic
use in food animal settings, CARB largely defers to the FDA, the federal agency
responsible for regulating these uses. As laid out in the following sections, however, there
are serious shortcomings to the FDA’s approach. We strongly question whether current
FDA efforts will lead to significant reductions in antibiotic use in food producing
animals, and consequently succeed at reducing the spread of antibiotic resistance.
To address these shortcomings, the Roadmap makes policy recommendations in
three key areas: decreasing antibiotic use, monitoring antibiotic use, and surveilling
antibiotic resistance. These recommendations are largely aimed at both federal and state
policymakers, but also go beyond government policy. For example, Appendix A offers
tools that medical professionals can use to help address livestock overuse of antibiotics
and Appendix C includes recommendations for universities, hospitals, and other buyers
of meat and poultry to use in procuring products.
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A. Decreasing Livestock Use of Medically
Important Antibiotics

It is the Commission’s shared sense that the statements in Box A (page 7) capture
important connections between antibiotic use and antibiotic resistance. They lead in
turn to the following general priorities for policy action, which are applicable not only
to the U.S. but also worldwide.
Priority #1: Ensure antibiotics are used only when necessary and effective, and when
non-antibiotic alternatives are unavailable, so as to reduce overall exposure of bacteria to
antibiotics (see Box B), and therefore the emergence and spread of resistance.
A)

When directed by a veterinarian, antibiotics should be used to treat

		

sick food-producing animals or those that have been exposed to an

		

animal with diagnosed disease.

B)

Antibiotics should not substitute for good animal management 		

		practices.
Priority #2: Reduce the sale and use of medically important antibiotics, putting the
highest priority on those deemed of greatest importance to human medicine.
Priority #3: Administer antibiotics for the shortest time period (duration) necessary.
While equally relevant in human medicine, these priorities are framed in terms of food
animal production because that is the focus of this report. These general priorities guide
our later recommendations for urgently needed changes to U.S. policy and practice.
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Box B: Exposing Bacteria to Antibiotics Raises Risk for Resistance
Bacteria can become resistant simply by errors being made as their DNA is copied, something that occurs
each time bacteria reproduce. They also can become resistant by picking up resistance genes from other
bacteria. Using an antibiotic allows resistant bacteria that can withstand the antibiotic to survive and
multiply. Other bacteria then can acquire resistance genes from these already-resistant bacteria. Because the
gut harbors billions of bacteria – in food-producing animals, as well as in people – it can be a hot spot for
exchange of resistance genes, including those acquired through the food supply.73,74,75,76
A plasmid is a small unit of DNA that can carry multiple resistance genes. Plasmids also are easily shared
among bacteria in human and animal guts. Non-resistant bacteria that are easily treatable with antibiotics
can become resistant to many antibiotics in an instant by picking up one of these plasmids.77 Plasmids often
carry genes that code simultaneously for resistance to both older and newer antibiotics, so that even when
people or animals are exposed to or treated with older or less important antibiotics, it still can fuel growth of
bacteria that are resistant to newer (often, more medically important) antibiotics. This underscores the need
to thoughtfully use all antibiotics – new or old, and human or not.

Use of Medically Important Antibiotics in Livestock
It is estimated that the U.S. is the second highest user of antibiotics in food animal production, with 13%
of the global total, behind China at 23%.78 The U.S. is one of the largest producers and exporters of meat
and poultry, globally, but also stands out compared to many other major livestock-producing countries in
terms of its consumption of antibiotics per unit of meat produced (See Figure 1). As incomes rise in many
developing countries, along with their demand for animal-based proteins, and more antibiotic-intensive
methods for raising food-producing animals are adopted by them, it’s projected that their share of global
antibiotics consumption also will rise.79
The Review on Antimicrobial Resistance, commissioned by the UK Prime Minister in 2014, compared
agricultural antibiotic use in European Union nations with use in other developed countries, such as
Australia, New Zealand and the U.S. Antibiotic use figures do not include ionophores or oligosaccharides.
At about 180 mg/kg, the estimated intensity of antibiotic use in the U.S. (measured as milligrams of
antibiotic active ingredient per kilogram of meat produced) is multiple times higher than countries such as
Australia, Denmark, and the Netherlands, while roughly commensurate with others, such as Germany and
Portugal.80
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Figure 1: Agricultural antimicrobial use (in mg/kg of animal body weight) in 25 EU/EEA countries,
Australia, New Zealand and the U.S.81

Work to dramatically reduce use of antibiotics in food-producing animals in the Netherlands serves as a good
case study for the U.S. As recently as 2008, the Netherlands used antibiotics about as intensively as the U.S.
does now. However, between 2009 and 2016, the use of antibiotics in Dutch livestock was reduced by more
than 64%, after adoption of the policies and approaches described in Appendix E.82 Despite these changes,
farmers maintained or increased their profits and levels of production, while the number of resistant bacteria
in livestock were reduced significantly.83,84 These comparisons strongly suggest similar reductions also could
be achieved in the U.S., if equivalent leadership were exerted, and policy changes were adopted.
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Antibiotics routinely administered en masse – even when under veterinary supervision – raise additional
concerns. Approximately 95% of the medically important antibiotics approved for use in U.S. foodproducing animals by volume are sold as additives to animal feed or water, to be administered to groups
rather than to individual animals.85,86 Mass administration to flocks or herds was the typical route of delivery
for medically important antibiotics given for growth promotion (now illegal in the U.S.), but it continues
to be the primary way antibiotics are administered for routine disease prevention purposes. When more
animals, and therefore more bacteria, are exposed to antibiotics it elevates the risk that resistance will develop
and spread.
Feed or water-administered antibiotics are often labeled to allow for use over a prolonged period of time.
About one-third of the medically important antibiotics still allowed for use in feed have no limits on the
duration of use.87 Even for those antibiotics for which there are specified durations, it would be within a
veterinarian’s prerogative to authorize several back-to-back, short duration uses for disease prevention, even
in the absence of a particular disease diagnosis. This kind of usage, in terms of selection for the emergence
and spread of resistance, would not appear to be much different than continuous in-feed use of low-dose
antibiotics for growth promotion.

The Current U.S. Approach
The U.S. is among the 193 U.N. member states that declared in September 2016 their commitment to work
together to address the root causes of the resistance crisis across human health, animal health and agriculture
settings.88 Members re-committed to preparing national action plans modeled after the WHO Global Action
Plan on Antimicrobial Resistance.
CARB, completed in March 2015, sets specific, numeric goals for reducing inappropriate antibiotic use
in hospitals and outpatient settings by 20% and 50%, respectively (see Table 1). Examples of inappropriate
antibiotic use include antibiotics that are wrongly prescribed for viral infections, such as colds; antibiotics
incorrectly given for an infection for which they lack antibacterial activity; and antibiotics prescribed for a
longer period of time than is necessary. CARB also sets specific goals for better surveillance and monitoring
of antibiotic resistance linked to drug use in human medicine.
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Table 1. Comparing CARB’s Approach: Reducing Antibiotic Use in People vs. FoodProducing Animals
Antibiotics in Human Medicine

Antibiotics in Food Animal Production

Starting point:

Starting point:

Accounts for 30% of all medically
important antibiotics sold

Accounts for 70% of all medically
important antibiotics sold

Preventive antibiotic normally not
used in the general population

Medically important antibiotics
routinely fed to flocks or herds for
disease prevention, absent a diagnosis of
disease

Preventive use in limited
circumstances, for example in
patients with pre-existing conditions:
Patients before surgery can get
antibiotics to prevent surgical site
infections

Until recently, antibiotics were allowed
to be used to speed up animal growth,
i.e. “growth promotion”

Dental patients with abnormal heart
valves get antibiotics prior to dental
procedures
CARB Includes:

CARB Includes:

Firm numerical targets for reduction
of inappropriate use in different
settings:

No targets for reduction

20% in inpatient settings
50% in outpatient settings

Relies on FDA’s elimination of growth
promotion uses, estimated at 10-15% of
use (at most):
Concern: While growth promotion use
has been eliminated, similar or identical
use can continue to “prevent” diseases in
animals that are not sick, as a substitute
for improved management practices
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CARB does not set meaningful goals related to
antibiotics used in food animal production. First, it
sets no numeric goals for reducing antibiotic use
overall, which is worrisome given the high volume
of use in the livestock sector. Second, current
national efforts to monitor antibiotic use on farms
are mostly non-existent and the integration of
antibiotic use data with surveillance of the spread
of antibiotic resistance is inadequate. Under CARB,
goals for addressing these shortcomings are sparse
and vague.

Brief History of FDA Efforts
More than four decades ago, the FDA made a
scientific finding that certain antibiotics given
to food-producing animals at “sub-therapeutic”
levels (e.g. for growth promotion, feed efficiency,
and disease prevention) posed a threat to human
health because of antibiotic resistance concerns.89
FDA subsequently proposed in 1977 to withdraw
approvals for such uses of penicillins and
tetracyclines, but it did not follow through.90 While
CARB largely defers to FDA to address antibiotic
use in food animal production, FDA’s efforts to
date have targeted only a small portion of total
antibiotic use. As described below, the agency has
set no targets for reduction of use, and has included
few safeguards to monitor and adjust for changes in
usage levels. Moreover, a recent assessment by the
independent Government Accountability Office
(GAO), published in March 2017, concludes that
without clearer objectives, still-inadequate data
collection and no metrics in place for measuring
effectiveness, the agency cannot know whether the
steps it has taken have improved the management of
antibiotics used in food animal production.91

Phase-out of growth promotion claims, but
approval for disease prevention use continues
In its 2013 Guidance for Industry #21392, the
FDA urged drug makers to voluntarily remove
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growth promotion language or “claims” from their
medically important antibiotic products sold for
use in animal feed or drinking water. Companies
removed those claims and FDA subsequently
codified the changes in January 2017. However, the
elimination of antibiotics for growth promotion
alone is not likely to significantly reduce antibiotic
use in food animal production; both the animal
pharmaceutical industry and the FDA estimate
that growth promotion use accounts for no more
than 10% to 15% of all antibiotic sold for use
in animals.93 Furthermore, many of the same
antibiotics sold for use as growth promoters are
also FDA-approved and labeled for the purpose of
disease prevention, including at dosage levels and
durations that are similar to or the same as those
previously approved for growth promotion.94,95
This means that mass administration of medically
important antibiotics for long periods of time may
continue.

Veterinary oversight without other safeguards
Under Guidance #213, the sale of medically
important antibiotics for use in feed or drinking
water for disease prevention, control or treatment
can continue, but the FDA recently put such uses
under the oversight of a veterinarian. Purchasing
the antibiotics requires a feed directive (called a
VFD) or a veterinary prescription.
However, there are no policies or tools in place to
monitor and track how well veterinarians oversee
or prescribe the use of these antibiotics in livestock
production. For instance, there are no systems to
compare antibiotic prescription patterns among
veterinarians, or even to identify high prescribers as
the first step in helping them modify their use of
antibiotics. In addition, there are no systems or
means for discouraging farms from shopping around
for a veterinarian who might be more willing than
his or her peers to prescribe antibiotics. In these
two respects, the U.S. suffers by comparison to
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Denmark and the Netherlands, where such systems
are in place (described on page X). Finally, U.S.
veterinarians are frequently employed by and write
prescriptions on behalf of large meat production
companies. A 2011 GAO report supports the
concern that conflicts of interest could interfere
with the determination of whether antibiotics for
these food-producing animals are in fact necessary.96

Recommendations to Decrease
Livestock Use of Medically Important
Antibiotics

Appendix E.) Analyses of their efforts have pointed
to target-setting as a key component of success in
both Denmark and the Netherlands.97
CARB also found value in setting reduction targets
in both inpatient and outpatient settings. We
recommend that similar reduction targets be
established in food animal production. Target setting
should be accompanied by strong data collection
programs and benchmarking to ensure that
reductions are achieved and high users are identified
for improvements.

To successfully combat the crisis of antibiotic
resistance, the U.S. must meaningfully reduce use of
antibiotics in food animal production, as well as in
human medicine. The recommendations below
draw on science and successful efforts to reduce
antibiotic use in human medicine in the U.S. and in
livestock production in Europe.

While reduction targets ideally would be set at the
federal level, state governments and even private
actors can make significant contributions by setting
their own targets.

We acknowledge there may be significant cultural
differences between the U.S. and countries such as
Denmark and the Netherlands that may affect how
some of our recommendations would be
implemented. However, many of these
recommendations already are being implemented in
the U.S. within human medicine (See Table 1), by
some U.S. food producers, and by some individual
states. Our broad recommendations also can be
adapted to different sectors and institutions (e.g.
hospital food service, restaurants, etc.) in ways that
the appendices to this report explain further.

We recommend a policy to phase out the routine or
programmed administration of medically important
antibiotics over long periods of time to flocks or
herds of animals. (‘Programmed’ use of antibiotics
refers to when animal management protocols or
guidelines have been written so that antibiotics are
regularly administered at a particular phase of
production, irrespective of any particular disease
diagnosis.) This can be combined with target
setting, as in the Netherlands, or pursued
independently as in Denmark. Both countries have
phased out antibiotic growth promoters and other
uses of antibiotics in the absence of disease, and
have achieved reductions of 45% to 60%. The
American Academy of Pediatrics98 and the
European Medicines Agency/European Food Safety
Authority99 also recommend only using antibiotics
to control or treat disease. The U.S. should follow
this lead.

Recommendation No. 1: Set targets for reducing
antibiotic use
Antibiotic use reduction targets are a wellestablished policy tool for achieving change. For
example, the Dutch livestock sector and
government were able to reduce sales and use of
antibiotics in food animal production by more than
60% in part by setting reduction targets. (See

Recommendation No. 2: Phase out routine or
programmed antibiotic use

Absent federal action, states also can take steps to
phase out routine or programmed antibiotic use in
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food-producing animals within their borders.
California has already done so by banning the use
of antibiotics for disease prevention “in a regular
pattern of use,” starting in 2018.100
The private and public sectors also can take action.
Major food companies that have instituted policies
to phase out the routine use of antibiotics for all or
some of the meat they source include Chipotle,
Chick-fil-A, Panera, Subway, KFC and McDonalds.
Public schools and hospitals also are increasingly
purchasing meat and poultry where antibiotics are
either disallowed or allowed only for treating or
controlling disease, but not allowed for
routine use for disease prevention. Even individuals
and families can set goals for themselves by
purchasing meat that reflects responsible antibiotic
use practices.
Both private and public sector actors should also
take action to support antibiotic stewardship
programs that emphasize better management
practices to prevent disease and reduce or avoid the
need for antibiotics in the first place.
Recommendation No. 3: Reduce the need for
antibiotics by adopting non-antibiotic best
practices, and by innovating new technologies, to
maintain animal health and prevent disease.
Even where antibiotics are being used to treat
disease, there often are opportunities to reduce or
avoid that use altogether by changing animal
management practices or investing in new
technologies, such as vaccines, to keep animals from
getting sick in the first place. Non-antibiotic disease
prevention is confirmed in both science and
practice. For example, in February 2017, the
European Medicines Agency along with the
European Food Safety Authority, published an
extensive scientific opinion detailing evidencebased management practices in food animal
production that reduce or avoid the need for
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antibiotics.101 Additionally, Kansas State
University102, the American College of Veterinary
Internal Medicine103, and the National Pork
Board104 also emphasize that responsible antibiotic
use involves reducing the need for antibiotics, such
as non-antibiotic measures to improve animal health
and prevent disease.
In the private sector, McDonald’s has incorporated
this principle into its 2015 Vision for Antimicrobial
Stewardship for Food Animals which articulates
four goals for its global meat supply chains,
including: “Utilize animal production practices that
reduce, and where possible eliminate, the need for
antimicrobial therapies and adopt existing best
practices and/or new practices that would result in
subsequent reductions of antimicrobial use.”105
Recommendation No. 4: Eliminate antibiotic use
where efficacy can no longer be demonstrated.
Antibiotic products that are FDA-approved for use
in livestock or poultry production must have been
shown to be efficacious at the time of approval.
Those approvals, however, may have occurred
decades ago and may no longer be accurate. Newer
data may be available showing reduced efficacy as a
result of significant changes in animal agriculture
since the drugs were first approved. Some drugs
were first approved over 50 years ago and have
never been re-evaluated by the FDA.
Recommendation No. 5: Prioritize the use of
antibiotics in veterinary practice that the WHO
does not categorize as “critically important” for
human medicine.
Among all antibiotics considered medically
important by the World Health Organization
(WHO)106 are some categorized as “critically
important” for human medicine. On this list are
several classes of antibiotics that are FDA-approved
for use in food-producing animals in the U.S.,
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including 3rd-generation cephalosporins, fluoroquinolones, macrolides, aminoglycosides, penicillins
and polymyxins.107,108 With respect to use of these
critically important antibiotics, we recommend
policies ensuring that in veterinary practice:
A. Antibiotics in the “critically important” category
are used only to treat animals sick with a specific
bacterial disease. Use of the subset of ‘highest
priority’ critically important antibiotics (also defined
by the WHO)109 should require testing that confirms
the bacterium involved is not susceptible to other
antibiotics.
B. Critically important antibiotics that are not
currently FDA-approved for food animal use in the
U.S., such as carbapenems, should never be
approved;
The Netherlands, as described in a recent European
Commission audit, provides one example of a policy
framework that prioritizes the use in animals of
antibiotics considered to be of lower importance for
human medicine.110 All antibiotics used in farming
there are available only under a veterinarian’s
prescription. Since 2012, a work group of the Royal
Netherlands Veterinary Association (KNMvD) has
had a system for classifying these antibiotics and
how they are to be used in order to reduce the
selection for antibiotic resistance. First-tier or first
choice antibiotics can be given empirically under an
existing farm treatment plan and protocol, after a
problem has been diagnosed. Second-choice
antibiotics are only used after a veterinarian’s clinical
exam and testing has substantiated the need for
them. Third-choice antibiotics are the most
restricted, because they are considered the highest
priority for human medicine, such as
fluoroquinolones and 3rd generation cephalosporins;
they are to be used in individual animals only after
veterinary testing substantiates that there are no
first- or second-tier alternatives.

Similar policies in the U.S. to prioritize the use in
animals of non-critically important drugs would be
meaningful, but only if combined with the phaseout of medically important antibiotics used
routinely in the absence of a disease diagnosis (such
as for disease prevention), per Recommendation
No. 2.
In addition to or absent U.S. federal action, state and
local governments could incorporate these
restrictions on the use of critically important
antibiotics in food-producing animals in legislation
or purchasing criteria. Private purchasers of meat
and/or poultry products likewise could build this
recommendation into their supply chain standards
or policies.
Recommendation No. 6: Bolster veterinary
oversight of antibiotic use with other
safeguards.
In Denmark and the Netherlands, stricter veterinary
oversight was instituted and combined with other
safeguards to counter the likely increase in
prescription use of antibiotics following restrictions
placed on growth promotion and disease prevention
uses. Those safeguards include: restrictions placed on
certain kinds of uses, restrictions on veterinarian
profits from the sales of antibiotics, and new
accountability measures such as benchmarks for
antibiotic use by farms and veterinarians (e.g.
“Yellow card” or comparable programs to identify
high users of antibiotics and help them to improve
their performance). (See Appendix E).
Some safeguards along these lines are already in
place in U.S. human medicine. The American
Medical Association, for example, cautions U.S.
physicians that profiting from the sale of healthrelated products, including antibiotics, from their
own offices creates a financial conflict of interest, is
unethical and therefore not allowed.111 Also, under
the Physician Payments Sunshine Act of the
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Affordable Care Act, manufacturers of pharmaceuticals as well as medical devices must divulge financial
payments to physicians and hospitals, and these become a matter of public record.112
The U.S. government can and should play a key role to ensure stronger veterinary oversight of antibiotic use
in food animal production. State governments also can implement strong data and benchmarking policies
regarding antibiotic use in food-producing animals within their borders. Similarly, major purchasers of meat
and poultry can track the use of medically important antibiotics in their supply chains and benchmark
performance to drive reductions.
Table 2. Comparing U.S. Veterinary Oversight Provisions to Denmark and the Netherlands

United States
Restrictions

Growth promotion uses ended;
Routine disease prevention allowed

Vet oversight mostly required,
except for select over-thecounter injectable antibiotics
Veterinarian
oversight,
accountability

No limits on profiting from sales
No tracking of how much
individual vets prescribe antibiotics
No farm registration of vets
required
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Denmark (DK) and the
Netherlands (NL)
Both DK and NL have banned
growth promotion and disease
prevention uses
Vet oversight of antibiotics
required in DK, NL
DK - Farms required to have a
contracted veterinarian at all times
NL - Requires farms to have a
one-to-one relationship with a
veterinarian.
DK - Vet profiting from direct sales
capped at 10% (profits hit 30%
before cap)
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B. Monitoring Antibiotic Use to Reduce Antibiotic
Resistance

The collection of antibiotic use data is critical for managing and minimizing antibiotic
resistance, as recognized by the GAO113, the World Organization for Animal Health
(OIE)114 and the WHO.115
Better data are essential to fully understand how and why antibiotics are used
in food animal production and how that use varies by species, region and over
time. Understanding patterns of use and trends in antibiotic resistance can help
policymakers direct resources so it has the greatest possible impact. It also will allow
for the success (or failure) of specific interventions to be better monitored so that
adjustments can be made. Similarly, food animal producers need better data to develop
improved antibiotic use strategies, including setting targets for and tracking progress
toward reducing unnecessary use.
The usefulness of antibiotic use data is influenced by the choice of metric in reporting
that data. The choice of a particular metric can, in turn, reflect the setting in which
antibiotic use occurs as well as the robustness of the underlying data. Also guiding the
choice of metric is the purpose for which those data are being utilized (i.e. tracking
trends in antibiotic use; comparing antibiotic use between countries or between
animal species; or for determining any association between particular antibiotic
uses and resistance).116
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The Current U.S. Approach to Data
Collection
Antibiotics sold for use in food animal production
far outstrip those sold for use in human medicine.
To successfully address the antibiotic resistance
crisis, reliable data on how and why antibiotics
are used in food animal production is a critical
element. Without such information, national
efforts to confront the crisis of antibiotic resistance
are likely to fall short.
In the U.S., data related to food animal production
are collected along three data streams. Since
2009, drug companies have been required to
supply the FDA with information on antibiotics
sales for use in food-producing animals, which
the agency publicly issues as an annual report. It
includes information on the intended route of
administration (e.g. via animal feed, drinking water
or injection), and the antibiotics’ dispensing status
(i.e. over-the-counter, prescription, or veterinary
feed directive). Starting in 2017, the FDA also will
require drug companies to estimate antibiotic sales
broken down by major food-producing species
(cattle, swine, chickens and turkeys). The agency
cautions that these estimates may be incomplete
and not match actual antibiotic use at the farm
level.
The U.S. Department of Agriculture (USDA)
collects the only publicly available data on actual
farm-level use of antibiotics. Data is collected
through voluntary farm surveys on animal health
and management, conducted since 1983 by the
agency’s National Animal Health Monitoring
System (NAHMS). Information for each livestock
sector is collected only once per five- to sevenyears; the questions asked can vary from one
survey to the next. Both factors make year-to-year
comparisons basically impossible, and trends more
difficult to establish, while also eroding the data’s
usefulness in assessing the impacts on farm practice
of any specific policy changes related to antibiotic
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use. Finally, the surveys are voluntary, and therefore
not comprehensive by definition.Voluntary surveys
also may be unintentionally biased, since farms
that choose to participate may not accurately
reflect the industry as a whole.
In 2011, the U.S. Government Accountability
Office summarized the program’s shortcomings as
follows:
“....NAHMS is limited by long lag times
(approximately six years) between surveys of the
same species, changes in methodology and survey
populations between studies, reliance on voluntary
participation by food animal producers, and
collection of qualitative, rather than quantitative
information on antibiotic use.”117
Further illustrating the shortcomings, the chicken
and turkey surveys do not ask about antibiotics
use (See Table 3). Only beef, dairy and swine
producers are asked about what antibiotics have
been used on their farms in the last six months,
the route of administration, the age of the
animals (e.g. nursery or finisher pigs), and general
reason for use (e.g. growth promotion, disease
prevention, disease control, disease treatment).
The USDA recently announced that antibioticspecific surveys for swine farms and beef feedlots
are being conducted in 2017.118 While they may
provide some additional data, these surveys will
carry the same aforementioned limitations as
other NAHMS surveys119, while also combining
reporting on antibiotics used for treatment,
control and prevention purposes so as to make it
impossible to distinguish between those uses.120
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Table 3: Overview of major poultry, livestock studies conducted by NAHMS, 2006-2016
Year studies were
conducted, 2006 - 16
Chicken

2007, 2010

Turkey

2007, 2010

Swine

2006, 2012

Beef (cow-calf)

2007

Beef (feedlot)

2011

Dairy

2007, 2014

Information on
antibiotic use

Information on
antibiotic resistance

The USDA collects some limited, additional antibiotic use data from farms as part of annual surveys of farm
finances in its Agricultural Resource Management Survey (ARMS) program, jointly conducted by the
National Agricultural Statistics Service (NASS) with the Economic Research Service.121 NASS also collects
important information on the number of animals raised in the U.S. that are needed to interpret antibiotic
use data. The ARMS surveys included questions about antibiotic use in swine farms in 2004, 2009, and 2015
and on broiler farms in 2006 and 2011. These surveys, however, contain much less detail on antibiotics than
the aforementioned NAHMS surveys; they provide only general information on whether or not a farm used
antibiotics for a specific purpose (e.g. growth promotion, disease prevention, or treatment), and provide no
information on specific antibiotics used. These data also carry the additional limitations of the data collected
under NAHMS as they are sporadic and voluntary.
In short, antibiotic use information available in the U.S. is simply inadequate to fully address the antibiotic
resistance threat to human health. Without more detailed and comprehensive information, we cannot have
an accurate picture of how antibiotics are sold, distributed, and used in food animal production. The absence
of this is likely to hamper policymakers and healthcare leaders trying to tackle antibiotic resistance because
changes and trends cannot be accurately tracked, and resources may not be focused where they are most
needed.

Examples of Comprehensive Data Collection Systems
Successful models do exist for collecting and analyzing how and why antibiotics are used in food animal
production (See Box C). In each model, the government, livestock industry and veterinarians all play
important, albeit somewhat different, roles.
In Denmark, a national database called VETSTAT serves as a repository for data on drug usage at the herd
level. It is collected from three sources allowed to dispense antibiotics: veterinary pharmacies, veterinarians
and feed mills.122 VETSTAT, funded by the Danish Ministry of Food, Agriculture and Fisheries, is then used
as a resource to set national goals and thresholds, as well as to benchmark antibiotic use at the individual farm
level. In the Netherlands, an expert panel of the independent Netherlands Veterinary Medicines Authority
(known as SDa), reviews the data from 40,000 livestock farms, sets benchmarks on antibiotic use and issues
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an annual report on its findings. The data come from the large animal production sectors themselves, which
have recently instituted centralized registration systems that monitor antibiotic use on all farms, and from
FIDIN, the federation of the Dutch veterinary pharmaceutical industry, which reports on annual sales of
antibiotics.
These different models for data collection Illustrate different approaches to ensuring farm anonymity. In the
Netherlands, the industry associations maintain and track the data and provide anonymized information on
usage to the independent SDa. In Denmark, the government can access farm-specific data more freely, but
the public must make a special request to access it.

Recommendations for Improving U.S. Data Collection
The following recommendations encompass a discussion of the essential data that should be collected (See
Box D), potential sources of data, as well as options for metrics that synthesize the available data and allow
for comparisons of antibiotic use.
Recommendation No. 7: Develop a system for collecting detailed, comprehensive data on actual
antibiotic use, and collect essential data
We call on federal agencies, working with states and producer groups, to develop a system for collecting
detailed, reliable data on the use (not just sales) of antibiotics at the farm level, or at the level of the
veterinarians overseeing their use.
The FDA acknowledges that gathering information on the way medically important antibiotics are
used is essential to measuring whether its current strategy is working to ensure that antibiotics are used
appropriately in food-producing animals. However, the agency has no system in place to collect ongoing
and comprehensive use data, nor does it have any stated intention to build such a system. Each of the
current separate programs collecting data pertaining to U.S. antibiotic sales or use – FDA’s collection of sales
data, USDA’s NAHMS surveys, feed mill records and existing state databases – should be molded into a
unified system modeled on the experience in Denmark and the Netherlands.
Development of unified data collection systems in Denmark and the Netherland has been critical to their
success in reducing antibiotic use (over baseline levels) by 47% and 64%, respectively. To ensure success,
or even to measure progress of CARB, the U.S. must also have a good data collection system. That system
should be mandatory, not voluntary, and should be comprehensive enough to encompass certain essential
data.
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Box C: Comparing U.S. Data Collection Efforts to Denmark and the Netherlands
The limited data on antibiotic use in U.S. animal agriculture stands in stark contrast to Denmark and the
Netherlands. Both countries have robust, profitable meat and poultry industries where they raise animals
in intensive, industrial-style operations not unlike those in the U.S. Both have adopted policy and practice
changes that have helped to significantly curtail unnecessary antibiotic use in food animal production. In
each country, the changes include improved monitoring of antibiotics sold and used in food-producing
animals as well as surveillance to identify patterns of resistance in people, retail meat and in food-producing
animals. Antibiotic sales, use and surveillance information for each country also are integrated into a
single annual report.123,124 No such integrated report is prepared in the U.S., as is discussed later. The
enhanced systems for collecting and integrating data in the two countries have informed additional policy
interventions over time by identifying areas in need of improvement. They also have made it possible to
benchmark how well veterinarians and/or farms use antibiotics relative to their peers. These systems have
been crucial in enabling the countries to reach their antibiotic use goals and reduction targets as well as
keep antibiotic resistance in animal populations at low levels. Data, in other words, are central to driving
improvements in antibiotic use.
Denmark – Responding to public concern about levels of antibiotic use in food-producing animals, and
possible impacts on human health, Denmark began taking a series of important steps in 1995, including
improving data collection. It established DANMAP, the Danish Integrated Antimicrobial Resistance
Monitoring and Research Program, which: 1) monitors antibiotic use in food-producing animals and people;
2) monitors occurrence of antibiotic resistance in bacteria from food-producing animals, food of animal
origin and people; 3) identifies trends and puts together information on associations between antibiotic
use and resistance; and 4) identifies routes of transmission and areas for further research.125 Individual farm
level data are collected from veterinarians, pharmacies and feed mills and reported to a centralized system
(VETSTAT).VETSTAT information can be accessed by farmers or veterinarians, allowing them to compare
their level of use to a national average.
The Netherlands – In 2009, public concern in the Netherlands led the four main livestock sectors (veal,
cattle, pigs and poultry), along with other stakeholders, to establish a task force on antibiotic resistance.
Later that year, industry and government together set a goal for reducing antibiotic use by 50% within five
years. The independent SDa was formed in 2010, and serves as a repository for sales data collected from the
pharmaceutical industry, and for prescription data collected by the livestock industry and then provided in
an anonymized form to the SDa. SDa is a public–private partnership between government, the Royal Dutch
Veterinary Association and the livestock industries.
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Box D: What Data Should Be Collected?
Certain minimum data are essential to capture a meaningful picture of how and why
antibiotics are being used in animal agriculture. It is critical to know:
		Antibiotic administered;
		
Species (pigs, turkeys, chickens, beef and dairy cattle) on which the
		
drug was used;
		
Purpose of use and/or indication (disease treatment, disease 		
		
prevention/control, type of infection such respiratory illness, etc.);
		
Route of administration (feed, water, oral, injection, intramammary,
		topical, other);
		
Volume of antibiotic active ingredient;
		
Duration of use; and
		
Number of animals receiving the antibiotic.
Ideally, the following additional information also would be collected to provide a more
complete understanding of use and resistance patterns:
		
Dose of the antibiotic administered;
		
Production class (dairy cattle vs. beef cattle, etc.);
		
Age of animal (sows vs. piglet; if interested in daily dose);
		Region;
		
Farm identification (potentially anonymous);
		
Veterinarian identification (potentially anonymous)
Data Sources
Data could be collected from several different sources, as described in the Danish and
Dutch examples. At the federal level, for example, FDA could collect information
from feed mills on antibiotics mixed into animal feed and then sold for use on farms.
Currently, it does not do this and feed mills are only required to maintain records and
make them available to the FDA, if requested. Similarly, the USDA could implement
a yearly survey representative of the food animal production sector to collect
information on how and why antibiotics are used.
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In absolute terms, especially relative to the
enormous potential economic losses if effective
antibiotics are no longer available in the future, the
near-term costs of building this system are unlikely
to be large relative to the magnitude of the threat.
For example, experts in Denmark indicate that a
recent overhaul of VETSTAT, their comprehensive
data collection system, is going to cost an estimated
$3.2 million; ongoing operations will cost an
additional $450,000 a year.
States and private actors in the U.S. also could play
significant roles in collecting and reporting data on
antibiotic sales and use. For example, California’s
law addressing antibiotic use in livestock includes a
requirement to monitor antibiotic sales and usage.
Professional livestock or veterinary associations
could collect and report use information to
the public, as they do in the Netherlands. Food
marketers and buyers also can help increase
transparency by requiring suppliers either to report
antibiotic use to them directly, or to participate in
government or other data collection systems.

Recommendation No. 9: Adopt a metric for
reporting data on antibiotic sales or use that
better allows trends to be identified, explained,
and compared.
Data on antibiotic sales or use are most useful in
a policy setting when they are expressed using a
metric that facilitates comparisons, such as across
time, animal species, or countries. Appendix A
describes different metrics in use today. Until a
better system is put into place to collect more data
(detailed in Box D) the U.S. should employ a metric
for reporting on antibiotic use that can inform its
efforts to eliminate unnecessary and inappropriate
use, as well as to allow for comparisons with other
countries. In the near-term, the U.S. can and should
employ the mg/PCU metric. This measures the
amount of antibiotics sold per amount of livestock
raised. The longer-term goal should be to transition
to use of an animal defined daily dose metric, a drug
and animal species-specific measure that requires the
collection of additional data.

Recommendation No. 8: Coordinate with and
learn from other countries in developing a
comprehensive data collection system.
The most efficient means to develop a U.S.
database on antibiotic use is to build on appropriate
models currently in place in Europe, modified to
accommodate how antibiotics are regulated and
distributed at the state and federal levels. The U.S.
can take advantage of the fact that several European
countries have already spent a decade or more
building comprehensive data collection systems, and
integrating them with national surveillance of trends
in antibiotic resistance. Also, in signing onto the UN
declaration, the U.S. signaled its commitment, to
cooperate to combat antibiotic resistance and the
global public health threat it represents.

C
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C. Enhancing Surveillance and Data
Integration to Inform Antibiotic Use Policy

The previous section described three streams of data currently being collected in
the U.S. concerning livestock use of antibiotics: FDA’s collection of sales data from
the animal drug makers; USDA’s periodic voluntary surveys of farms; and the NASS
collection of data on numbers of animals raised. The National Antimicrobial Resistance
Monitoring System (NARMS) represents a fourth stream of data collection. NARMS
is a surveillance program that monitors for antibiotic resistance among bacteria
isolated from people, retail meat and food-producing animals at the slaughterhouse,
and is discussed in greater detail below. Individually, each data stream provides some
meaningful information, but the usefulness of the data is shortchanged by a failure
to combine the different data streams into an integrated analysis to provide a more
comprehensive picture of antibiotic use in food-producing animals. What follows
is a more detailed discussion of the NARMS surveillance program, followed by
recommendations for better integration of the various streams of data collected by
the federal government.
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National Antimicrobial Resistance Monitoring System (NARMS)
Since 2003, the NARMS program has been providing surveillance on a national basis for antibiotic
resistance in enteric (‘gut’) bacteria. NARMS surveillance work is conducted by three federal agencies
(CDC, FDA and USDA) and studies bacteria collected from people, the retail meat supply, and foodproducing animals, respectively.
In short, public health laboratories submit bacteria from cases of human infection to NARMS, where, led by
the CDC, they are tested for resistance to antibiotics. FDA receives bacteria from samples of retail chicken,
ground turkey, ground beef and pork chops collected each month by laboratories in 14 states. FDA scientists
further characterize the bacteria and test them for resistance to antibiotics.126 USDA scientists conduct
similar tests on bacteria obtained from food-producing animals at federally inspected slaughterhouses and
processing plants.
NARMS is valuable for monitoring trends in antibiotic resistance in people, food and in food-producing
animals. NARMS would be stronger, however, if it reflected emerging research techniques and the latest
science. Its failure to do so means that the NARMS program is falling behind in meeting its stated goal to
“protect public health by providing information about emerging bacterial resistance”.127 Below are three
specific shortcomings of the program, reflecting an outdated approach:
No consistent monitoring of indicator bacterial species. NARMS currently focuses too narrowly on bacteria
that are conventionally considered to be foodborne causes of infection, such as Salmonella or Campylobacter.
Other bacteria, such as Escherichia coli and Enterococcus spp. also are found in the food supply, can cause disease
and are considered to be “indicator” species that can signal existence of a broader reservoir of antibiotic
resistance. Only four of the 14 state laboratories participating in the NARMS retail meat program collect
samples of these so-called indicator bacteria for later testing by FDA for antibiotic resistance. In addition,
there is a lack of uniformity between agencies in terms of which indicator species they monitor (see Table
4). Both problems create a significant challenge for NARMS to track antibiotic resistance in a coordinated
and complementary manner along the entire food supply chain.
Table 4: Overview of NARMS Testing According to Bacterial Species
Bacterium
Salmonella
Campylobacter spp.

Tested by CDC

Tested by FDA

Enterococci spp.
E. coli
E. coli O157
Shigella
Vibrio spp.
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Tested by USDA

Does not apply genetic sequencing to indicator
bacteria and pathogens other than Salmonella.
Federal efforts to begin sequencing the entire
genome of certain bacteria collected under
NARMS have focused almost entirely on
Salmonella.128 However, recent studies show that
other indicator bacteria, such as E. coli, are the most
common bacteria in livestock environments found
to be carrying genes that easily spread resistance
to antibiotics of last resort (such as colistin or
carbapenems) to other bacteria.129 Clinicians rely
upon these last resort medicines to treat lifethreatening infections when other drugs have failed,
or are likely to fail.
There are two key reasons to sequence the genes
of bacteria such as E. coli or Enterococcus spp. and not
just Salmonella. First, resistance genes found in either
one are important because that resistance could
subsequently be shared between the two groups of
bacteria, in any environment. Second, these bacteria
are more commonly found in livestock and other
environments so resistance trends are more easily
monitored in these bacteria. For both reasons,
sequencing only the genomes of Salmonella bacteria
would be likely to contribute to incomplete
identification of and surveillance for antibiotic
resistance genes in livestock environments.
Metagenomics is a powerful technique, first named
in 1998130, that looks at the DNA recovered from
all bacteria in a particular environmental sample.
Because the FDA and USDA already have the
ability to sequence genes of individual bacteria,131,132
that capability likely could be easily adapted to
detect resistance from all of the bacteria isolated
from a particular animal or meat sample. We can
and should expect the NARMS program as well
to use metagenomics to comprehensively detect
emerging resistance in all bacteria, and not just in
Salmonella, Campylobacter, E. coli and Enterococcus spp.

Fails to test for resistance to all antibiotics relevant
to human medicine. NARMS’ limitation is that the
panel of antibiotics to which bacteria are tested
for resistance will vary according to the species of
bacteria being tested, and that these test panels also
are too limited in scope to fully assess reservoirs of
resistance. NARMS antibiotic susceptibility testing
focuses only on classes of antibiotics used in food
animal production and/or the classes commonly
used to treat human infections. This overlooks
other antibiotics of importance to human medicine.
Colistin is an example of an antibiotic that has
only recently become more common in human
medicine, as resistance to other, less toxic agents
forced practitioners to return to using it. And now
colistin-resistant bacteria, likely enriched by overuse
of the drug in pig production (outside of the U.S.),
are spreading around the world.133,134

Roadmap Recommendations for
Enhancing Surveillance and Data
Integration
In light of the shortcomings of U.S. surveillance
of antibiotic resistance, we propose the following
recommendations:
Recommendation No. 10: Integrate available
data into a single, comprehensive report
CDC, FDA, and USDA, should publish a joint,
integrated report that summarizes the following:
antibiotic resistance data (NARMS, NAHMS),
antibiotic sales data (ADUFA, IMS Health135),
antibiotic use data (NAHMS, CDC136), and
livestock production statistics (USDA/NASS). The
report should draw the best connections between
the data possible. In the absence of a national report,
state policymakers can publish a regional report by
requesting state level resistance data from NARMS
and livestock production statistics coupled with
new surveillance of state-level antibiotic use, such as
will soon be collected in California.
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The annual DANMAP and NETHMAP/MARAN
reports are examples of integrated, comprehensive
reports that combine data on antibiotic use/
sales and antibiotic resistance.137 Both serve as
foundational documents for effective policymaking
in both countries. Reports from both countries
also contain additional information such as yearly
livestock/production data (such as that available
from USDA138 in the U.S.), and provide a basis
for a rough metric that facilitates international
comparison of milligrams of antibiotics used or
sold per kilogram of animal weight after slaughter.
Recommendation No. 11: Improve surveillance
to detect new and emerging resistance threats
The public health goal of any surveillance system
should be to detect problems earlier rather than
later. Early detection is more likely to result in an
intervention that succeeds in addressing problems
that arise. Later detection, on the other hand, may
result in being able to recognize that a problem
exists, but not being able to do anything about it.
In order to improve and/or expand upon the scope
of NARMS current surveillance, the government
agencies responsible for the program should
leverage the latest science to elucidate new and
emerging health threats from antibiotic resistance.
For example, recent scientific studies clearly
indicate that multidrug-resistant S. aureus bacteria,
including MRSA, are present in food-producing
animals and on U.S. retail meats.139,140 These
“livestock associated” antibiotic-resistant bacteria
have been found to colonize the nasal passages of
swine and poultry workers, and also can cause skin
and soft tissue infections in workers, as well as other
community members.141,142,143 In addition, certain
strains of disease-causing E. coli bacteria (extraintestinal pathogenic E. coli, or ExPEC) that can
be transmitted from food-producing animals/retail
meat to people have been characterized by several
studies as a probable source of human urinary tract
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infections.144,145 Some of these EXPEC bacteria
produce an enzyme called extended-spectrum
beta-lactamase (ESBL) which mediates resistance
to a number of important and often-prescribed
antibiotics, such as penicillins and cephalosporins.
Finally, transmissible plasmids have been discovered
recently on U.S. pigs146 or on pig farms147 that
carry resistance to colistin or carbapenem, two
antibiotics considered to be of last resort for some
of the deadliest antibiotic resistant bacteria we face
today. When genes that are resistant to both of these
medicines eventually land on the same plasmid, and
that plasmid spreads to other bacteria, it will mark
the emergence of widespread untreatable infections.
This discovery on U.S. pig farms lends weight to
the conclusion that there are resistance threats in
the food supply chain that are not being adequately
monitored.148 Of 15 serious and urgent antibioticresistant threats identified in a 2013 CDC report, at
least eight are bacteria that have been detected both
in U.S. food-producing animals and in retail meat
from the U.S. or abroad.149 Three of these (MRSA,
VRSA, and multidrug-resistant Pseudomonas
aeruginosa) are not captured by the current
surveillance system, and another two are only
partially captured (CRE, ESBL Enterobacteriaceae).
As a surveillance system, NARMS suffers because it
does not consistently look for antibiotic resistance
among newly emerging pathogens or among
bacteria where important reservoirs of resistance are
first thought to emerge. We therefore recommend
the following specific expansions:
11a. Expand surveillance for emerging resistance
using next generation sequencing technology.
Both FDA and USDA currently sequence the
genomes of traditional foodborne pathogens tested
through NARMS. These sequencing efforts should
be expanded to a wider array of bacteria, including
E. coli and Enterococcus which can be important
reservoirs of resistance that can spread to other
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bacteria. The agencies should set up a publicly accessible database or make use of existing databases for the
timely release of genome sequencing data.150
11b. Expand surveillance for important emerging pathogens. Emerging threats from pathogenic bacteria
could be better characterized and assessed if NARMS were expanded to include additional surveillance for
S. aureus and ExPEC E. coli from people, retail meat and food-producing animals, as well as testing these
bacteria for susceptibility to antibiotics. If sufficient funding from regulatory agencies is not available, a less
preferable alternative would be for NIH or CDC to authorize research funding for the proposed expansion
of NARMS testing, on a pilot basis.
11c. Pilot test approaches that comprehensively detect resistance in all bacteria in a sample. As noted
above, the NARMS program can and should explore the use of metagenomics to detect emerging resistance
in all bacteria, and not just in Salmonella, Campylobacter, E. coli and Enterococcus spp. With metagenomics, the
resistance information collected also is no longer limited to a few antibiotics; rather, the results from a sample
are compared, simultaneously, to a comprehensive database collection of known resistance genes. Again,
expanding metagenomic analysis within NARMS could take place as a pilot, if funds couldn’t be secured
through regular budgetary means.
11d. Expand surveillance at the state level. Beyond the federal level, state veterinary laboratories have
an important role to play in improved surveillance by publicly reporting on resistance found among food
producing animals. For example, in 2016, the Minnesota Veterinary Diagnostic Laboratory published findings
on resistance in Salmonella from clinical samples from 2006 to 2015 in swine and cattle.151 Public reporting
on resistance from food animal clinical isolates at the regional level on a yearly basis would help address the
important data gap regarding antibiotic resistance on the farm.

Conclusion

35

Conclusion
Antibiotic resistance is an urgent public health threat that demands immediate action.
Drug-resistant infections are on the rise, making antibiotics less effective and putting
routine and common and life-saving procedures in jeopardy. Antibiotic resistance
is changing the practice of modern medicine by compromising our ability to treat
sick people and animals. Additionally, it is a serious threat to economic and national
security. It is estimated that by 2050 a person will die every three seconds from a drugresistant infection and $100 trillion in global economic productivity will have been
lost.152
Antibiotic use and overuse in people and in food animal production are important
drivers of antibiotic resistance. However, this report focuses specifically on antibiotic
use in food-producing animals because 70% of medically important antibiotics sold in
the U.S. (i.e. those identical or belonging to the same class as antibiotics used in human
medicine) are sold for use in food-producing animals, not people. Additionally, the
U.S. has taken significant steps in promoting better antibiotic stewardship policies and
programs in human medicine, but falls woefully short in doing the same as it relates to
food animal production.
This Commission wants to keep the existing arsenal of antibiotics effective for as
long as possible. We came together to craft this policy roadmap because we strongly
believe the U.S. cannot fully respond to this public health crisis unless it does a better
job to address the contribution to antibiotic resistance antibiotic use in food animal
production.
Our recommendations are steps that will help ensure that on-farm use of medically
important antibiotics is monitored and reduced, and that there will be adequate
surveillance of the development and spread of antibiotic resistant bacteria. Success, we
believe, depends on leadership that builds on approaches that have proven successful
elsewhere. While state and federal policymakers have important roles to play, action is
need from all stakeholders. Health professionals and hospitals, as well as food companies
and other major meat and poultry purchasers also have key roles to play. The appendices
that follow outline actions for each sector.
We all stand to lose when antibiotics no longer work. Steps must be taken today to help
ensure that our existing supply of antibiotics stay as effective as possible, now and for
future generations.
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Appendix A: Metrics for Reporting
on Antibiotic Use in FoodProducing Animals
Use of antibiotics in food-producing animals is an
important contributor to the selection and spread
of antibiotic resistance. As a result, many countries
have established national programs to monitor
and report on the sales and/or consumption of
antibiotics in this sector. Comparing results from
different places or authorities is complicated. They
may use completely different metrics. Even when
using the same basic metric, the methodology used
to calculate it may differ. Two countries may differ
in the dosages they authorize for a certain antibiotic,
or in the correction factor they employ for longacting antibiotic products.1 This appendix describes
different metrics that the U.S. might employ in
reporting its data on antibiotic sales and use, as well
as examples of how different countries calculate
those metrics.

What Metrics Should Be Used?
In the near-term, the U.S. has data sufficient to
report on antibiotics sales/use using the metric of
milligrams/population corrected unit (mg/PCU),
although it does not currently do so. The mg/PCU
metric compares the amount of antibiotics used, or
sold for use, in food production to the total weight
of animals being produced. The denominator, the
population correction unit (PCU), is a calculated
estimate of animal weight; it is a surrogate for the
animal population at risk, one that normalizes
antibiotic sales by animal population in individual
countries.
In essence, the PCU for each animal category is
calculated by multiplying numbers of slaughtered
animals (cattle, pigs, lambs, poultry and turkeys) and
other livestock animals (dairy cows, sheep, sows and
horses) by the theoretical weight at the time
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most likely for treatment. Adjustments are made for
the numbers of animals exported or imported for
fattening or for slaughter (cattle, pigs and poultry)
multiplied by a standardized weight.2
The independent European Surveillance of
Veterinary Antimicrobial Consumption (ESVAC)
project already collects such data from 29 countries
across Europe. Its 2014 report, for example, demonstrates that 68.4 mg / per population corrected
unit (PCU) of antibiotics were sold for use in
food animals in the Netherlands, in the midrange
of 3.10 mg/PCU (Norway) to 418.8. mg/PCU
(Spain).3 We believe data for calculating both
numerator and denominator of this metric also
are currently available in the U.S. The FDA issues
annual reports on antibiotic sales for use in food
producing animals.4 Meanwhile, the USDA collects
and maintains livestock and poultry production data,
including the pounds produced,5as well as data on
imports of meat and poultry products, and in the live
animals from which those products are derived.6

An alternate metric, once more
detailed data are available
A more desirable metric for reporting antibiotic
use information in the U.S. would be one based
on animal defined daily dose7, a numerical measure
of drug consumption that indicates the daily
maintenance dose needed for a particular use and
active ingredient in a particular species (and age
group, if relevant). This metric already is widely used
within the European Union; its adoption by the
U.S. would allow for the future comparison of the
U.S. and other important food animal-producing
countries. Its use in the U.S. would first require
collection of detailed and comprehensive antibiotic
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use data down to the farm level that is not currently done in the U.S., nor is yet under consideration. There
are several advantages to using this metric, rather than mg/PCU.
This second metric adds another layer of important information – namely, the potency of the particular
antibiotic used is built into the metric.8 This metric also can facilitate the comparison of trends in antibiotic
use over time, even if the potency of the antibiotics used varies over that time period.9 Finally, it allows for a
more meaningful comparison of antibiotic use in food animal production and in human medicine. Different
European entities use variations on this second metric that differ depending on the methodologies used to
calculate them (see Table A).10

Table A: Variations on an Animal Defined Daily Dose metric.
Metric

Explanation

Metric
used in

ADDDK

The ADDDK is the assumed average maintenance dose needed
to treat one kilogram of animal during one day for the main
indication in the target species, in accordance with Denmark’s
authorizing document for that product.1

DANMAP,
2009-2011

Animal Daily Dose
(Denmark)

The DADDDK is specified for a particular animal species. It
is the average maintenance dose (in mg/kg) per day for a
DADDDK
drug used for its main indication in the appropriate animal
Defined Animal Daily
species.12 The DADDDK is not defined at product level but for
Dose (Denmark)
each antibiotic agent, administration route and animal species
and when appropriate, also age group.

DANMAP,
2012 - present

Based on national antibiotic usage data, the ‘Defined Daily
Dose Animal’ is a metric used to determine the amount of
antibiotics used within a particular livestock sector, irrespective
DDDANAT
of any differences between farms in the sector; it is expressed
Defined Daily Dose as DDDA/animal year.13 The DDDANAT is determined
Animal (Netherlands) by first calculating the total number of treatable kilograms
within a particular livestock sector for a specific year, and then
dividing this number by the average number of kilograms of
animal present within that sector.

Maran/
NethMAP
Reports
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Appendix B: Tools for Health
Professionals To Improve Use of
Medically Important Antibiotics in
Livestock
Health professionals, their institutions and
professional organizations are on the front lines of
the antibiotic resistance crisis. Each should be fully
committed to antibiotic stewardship to preserve the
effectiveness of existing antibiotics for as long as
possible, and ultimately to better protect the public
against rising rates of antibiotic resistant infections.
Healthcare professionals around the world are
leading antibiotic stewardship efforts in hospitals
and outpatient settings. There is also an opportunity
for health leaders to help end the overuse and
misuse of antibiotics in food animal production.
Of all medically important antibiotics sold for
use in the U.S., 70% of them go to food animals,
not people. Most of those antibiotics are massadministered to groups of animals where there is
neither a diagnosed disease, nor a working diagnosis.
Antibiotics are routinely fed to flocks and herds as a
quick fix, often in place of better hygiene, nutrition,
animal husbandry or management practices – all of
which can help prevent the need for antibiotics in
the first place.
In May 2017, a panel of experts in human
and veterinary medicine, infectious diseases,
epidemiology, public health and microbiology
issued a Policy Roadmap to Reduce Antibiotic
Use in Livestock http://battlesuperbugs.com/
PolicyRoadtrip. While the recommendations in
the document mainly pertain to leadership needed
from state and federal policymakers, there also is
much that can be accomplished by clinicians, their
professional groups and institutions.

Using Existing Toolkits
A toolkit1 recently released by the Clinician
Champions in Comprehensive Antibiotic
Stewardship (CCCAS) collaborative – a joint
initiative of the Pediatric Infectious Diseases Society
(PIDS), Sharing Antimicrobial Reports for Pediatric
Stewardship (SHARPS), the Pediatric Infectious
Diseases Society (PIDS) and Health Care Without
Harm (HCWH) – specifically addresses the role
of clinicians and healthcare facilities in promoting
comprehensive stewardship of antibiotics in both
food production and clinical practice alike. It states:
“It is imperative that antibiotic stewardship
programs seeking to preserve the effectiveness of
existing antibiotics in human health also consider
strategies that reduce overuse of antibiotics in the
agricultural sector. This module provides the tools
to incorporate this important aspect of stewardship
into your program. In addition to bringing this to
the forefront of hospital- based care, we aim for
this comprehensive approach to translate to the
community setting as well, via patient education in
ambulatory settings.”
Here we highlight just a few of the strategies
and resources covered by that Toolkit. They
track some of the seven core elements of successful
antibiotic stewardship programs outlined by the
CDC2. Committed Leadership; Accountability;
Drug Expertise; Action; Tracking; Reporting; and
Education.
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Next Steps for Hospitals, Health Organizations, Health Professional Groups
Leadership Commitment
Make a strong statement by your institution in support of antibiotic stewardship that includes the
phase-out of medically important antibiotics being routinely used in food animal production, and the
importance of health organizations and facilities making purchasing decisions consistent with that goal.
Action, beyond your facility
Endorse hospitals associations, medical schools and universities making their own statements to support
phase-out of medically important antibiotics for routine use in food animals.
Expand your modeling and leadership of antibiotic stewardship organization-wide by passing policy
guiding your procurement of meat and poultry products.

Next Steps: Individual Champions for Antibiotic Stewardship
Nurture Committed Leadership
Be prepared to explain to your leadership why buying meat raised where medically important antibiotics
have not been routine used is clinically relevant, doable and important.
Make sure you know which antibiotics are used in food animal production, and be familiar with
mechanisms of plasmid transferability, cross-selection and co-selection, so as to explain how antibiotic use
on farms can spur development and spread of resistance to antibiotics from both related and unrelated
classes.
To make your best case, anticipate questions about costs, and options for forward steps. The CCCAS Toolkit
links to such presentations.
Accountability / Expertise

All health professionals should:
Embrace a One Health approach to antibiotic resistance, meaning that misuse or inappropriate use of
medically important antibiotics, whatever the setting, is a shared responsibility.
Hold your profession responsible for making antibiotic resistance, and the fight to keep antibiotics effective, a
priority policy, especially including taking strong policy positions on antibiotic use in non-human settings.
Hold yourself accountable for understanding how the meat and other food products served in your facility,
or at your lunches, meetings and conferences, is purchased.
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For those leading Antibiotic Stewardship Programs (ASPs):
Incorporate strategies to reduce antibiotic use in food animal production into your ASPs.
Invite facility food service leaders and dietitians onto your antibiotic stewardship team.

Action
Help draft and be a champion for your hospital/clinic, institution, or professional society to pass a policy
resolution to phase-out the procurement of meat and poultry produced with the routine use of medically
important antibiotics, perhaps modeled on the following draft.
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DRAFT Resolution
Ending Medically Important Antibiotic Use for Routine Disease Prevention
SUBJECT: No Routine Use of Antibiotics Important to Human Medicine in Food Animal Production
INTRODUCED BY:
WHEREAS, the World Health Organization warns that unless we act urgently, the world will enter a ‘postantibiotic era’ where even common infections will again kill patients3;
WHEREAS, The Centers for Disease Control and Prevention (CDC) estimates conservatively at least 23,000
patients in the U.S. already die each year from antibiotic‐resistant infections4;
WHEREAS, Antibiotic use and overuse are principal drivers for the emergence and spread of antibiotic resistance;
WHEREAS, Of all U.S. sales of medically important antibiotics (e.g. those from classes important to disease
treatment in humans), about 70% are products for use in food animals, and the remainder for use in human
medicine, according to the Food and Drug Administration (FDA)5;
WHEREAS, The FDA’s National Antibiotics Resistance Monitoring System reports that antibiotic-resistant
bacteria have become a common fixture in retail meat6;
WHEREAS, An ever-larger, but already compelling body of evidence demonstrates that this large-scale use of
medically important antibiotics in food animals contributes to the development and spread antibiotic resistance,
including to human populations7;
WHEREAS, In January 2017, and after approximately seven decades of use, the FDA finally effected the end of
medically important antibiotics being mass-administered to flocks and herds in animal feed or water, specifically
for the purposes of growth promotion or increased feed efficiency8;
WHEREAS, FDA continues to allow the routine administration of medically important antibiotics to flocks and
herds for ‘disease prevention’ in the absence of a disease diagnosis, and at dosages identical or similar to those used
for growth promotion.9
WHEREAS, Improved collection and public reporting of data on sales of antibiotics for use in agriculture –
including parsed out data to illuminate in which animal species and for what particular purpose such antibiotics
are used – is fundamental to efforts by health officials and researchers to both better understand development and
spread of antimicrobial resistance, and to assess the efficacy of any steps taken to address it.
Be it resolved that: Our [insert your professional organization] supports federal and state efforts to phase-out or
ban routine or regular addition of antibiotics to animal feed or water for the purpose of disease prevention.
Be it resolved that: Our [insert your professional organization] recognizes that to model antibiotic stewardship,
and to do our part to help keep existing antibiotics more effective for longer, it’s important to set a goal of
purchasing meat and poultry products from operations that only allow use of medically important antibiotics for
animals that are sick with diagnosed disease, and never mass administered to herds or flocks for [routine] disease
prevention.
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Appendix C: Tools for State and Local Governments to Improve Use of
Medically Important Antibiotics in Livestock
While federal action is important in order to make progress on reducing unnecessary antibiotic use and
addressing antibiotic resistance, many other actors have essential roles to play, particularly when it comes to
uses of the drugs in food animal production. State and local governments can take considerable action to
ensure that antibiotics are not overused in the livestock sector.
State action can move the market and drive improved antibiotic use practices while reducing risk for their
citizens, demonstrating the feasibility of alternative approaches, and laying the groundwork for eventual
action at the national level. California has shown early leadership on the issue, passing legislation to curtail
the routine use of antibiotics and institute monitoring of antibiotic use and sales.
In addition to laws that address how antibiotics are used, state and local actors can also make procurement
choices to prioritize and increase the purchase of meat and poultry raised without the routine use of
antibiotics in the absence of diagnosed disease and support producers that are using antibiotics responsibly.

The California Model: Legislation1 to Reduce and Monitor Livestock Antibiotic Use
California provides a model for other states to draw on for their own efforts to reduce unnecessary use of
medically important antibiotics in food animal production. Key features of California’s legislation include:
Requires veterinary authorization for use of medically important antibiotics.
Prohibits routine disease prevention use of medically important antibiotics.
Allows use for:
- Treatment of sick animals;
- When necessary for surgery or medical procedures;
- To control the spread of disease outbreaks; or
- For prophylaxis to address an elevated risk of contraction of particular
disease or infection (as long as the use does not constitute a “regular pattern of use”
Requires the California Department of Food and Agriculture to monitor sales and usage to help
producers improve antibiotic use practices
Requires the development of guidance on antimicrobial stewardship to help producers improve 		
antibiotic use practices
Requires a report to the legislature on progress made
Other Options for State Action to Reduce Livestock Antibiotic Use
Establish targets for reducing the sale or use of antibiotics in food-producing animals in the state
(e.g. a 50% reduction relative to a benchmark year).
Phase out all use in food-producing animals of certain antibiotics that are critically important to
human medicine.
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Procurement by State and Local Government Agencies
States and local governments could set targets for procurement of meat and poultry produced without
the routine use of antibiotics. A large portion of the chicken industry has already made commitments to
eliminate the routine use of medically important antibiotics and progress towards those commitments. State
and local governments could prioritize meat and poultry purchases from producers with such commitments,
particularly those that adhere to third-party verified standards such as the Certified Responsible Antibiotic
Use (CRAU) (add link) standard for poultry or otherwise require that the suppliers refrain from the use
of medically important antibiotics for growth promotion and prevention. Other standards and claims with
strong antibiotic use provisions include Organic, Humane Certified, Animal Welfare Approved, Raised
Without Antibiotics (Process Verified Program), and Global Animal Partnership (GAP).
State or Local Legislation on Reporting of Antibiotic Use Practices in Meat Supply Chain
States or cities also could enact legislation to require grocery stores in their jurisdictions to report to the city
or state the antibiotic use practices associated with the meat or poultry they sell. The city or state could then
analyze this data and make information and guidance available to the public.

Endnotes
1 A copy of the bill, Senate Bill 27 (SB 27), is available here: http://leginfo.legislature.ca.gov/faces/billNavClient.
xhtml?bill_id=201520160SB27. The bill also bans growth promotion use of medically important antibiotics, but that
simply replicates FDA regulations.
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Appendix D: Tools for Restaurants, Food Retailers and Food
Management Companies to Improve Antibiotics Use in their Meat and
Poultry Supply Chains
Consumer demand for meat and poultry raised with responsible antibiotics use practices continues to rise.
People are rightfully concerned that antibiotic overuse in livestock and poultry exacerbates the public health
crises of antibiotic resistance. By preferentially choosing meat raised with responsible antibiotic practices, the
public is sending a clear signal to the livestock industry that they need to reform current practices. Major
buyers of meat and poultry are sending a similar signal to the livestock industry. The 2016 Chain Reaction II
Antibiotics Scorecard, released by several NGO groups, ranked the antibiotic policies and practices of the top
25 restaurants in the United States.1 Nine of 25 chains earned passing grades, thanks in large part to strong
policies for chicken supplies. The number of companies with passing grades doubled from 2015 to 2016.
Similarly, leading health systems throughout the U.S. have set impressive goals around responsible meat and
poultry procurement; in some cases, up to 60% of a health system’s purchases are comprised of meat raised
without routine use of antibiotics.2,3
The good news for major buyers throughout the food sector is that availability of supply is growing to meet
demand, especially in the chicken industry. Major chicken suppliers like Tyson, Perdue, and Foster Farms have
either made commitments to phase out routine antibiotics use of medically important antibiotics in their
supply chains or have already done so.4,5,6 Pilgrim’s Pride committed 25% of its vast chicken supply to be
raised without antibiotics by 2020.7
There are signs of progress in the pork industry as well. Since 2016, Smithfield (the largest pork producer
and processor in the world) and Tyson have launched product lines of raised-without-antibiotics pork that
are meant for retail and food service sectors.8,9 Positive signs are also beginning to emerge from the beef
industry: Cargill announced in April 2016 that it would cut its use of medically important antibiotics by 20%
in 1.2 million cattle.10 This is a virtuous cycle: the more consumers, foodservice, and institutional buyers ask
for responsibly raised meat, the more the industry responds.
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Responsible Antibiotics Use Procurement Toolkit
We encourage all major buyers – whether at a grocery chain, a restaurant, or a foodservice operation – to
set clear antibiotic use policies governing meat and poultry procurement decisions at their company, school,
and/or hospital. These policies should have three key components and be integrated into bidding processes
and contracts:
1.

A time-bound commitment to phase out routine use of medically-important antibiotics, i.e. for disease
prevention; use of antibiotics for treatment of sick animals or to control identified disease outbreaks need
not be limited.

2.

A requirement that production claims be verified by a 3rd-party auditor to provide assurance that
antibiotics use practices match company policies. Verified standards and claims with strong antibiotics
use provisions include the Certified Responsible Antibiotic Use (CRAU) standard for poultry; Certified
Organic; Certified Humane; Animal Welfare Approved; Raised Without Antibiotics or No Antibiotics
Ever (if compliant with USDA Process Verified Program), and Global Animal Partnership.11,12,13,14,15,16 A
producer could also work with the USDA to develop a company-specific Process Verified Program that
complies with an antibiotics policy that bans medically important antibiotics for growth promotion and
routine disease prevention uses.

3.

A publicly available, annually updated progress report to ensure that customers and investors (if
applicable) are informed.

We also encourage institutional and foodservice purchasers to do the following:
1. Ask their meat and poultry suppliers about their antibiotic use practices to improve transparency
about which antibiotics are being used by supplying farms, in what quantities, and for what
species. Even if this information is kept confidential, it sends an important signal to producers.
2. Engage in public policy to contribute to solutions at federal, state and local levels.
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Endnotes
1 2016 Chain Reaction Antibiotics Scorecard (NRDC.org): https://www.nrdc.org/resources/chain-reaction-how-toprestaurants-rate-reducing-antibiotics-their-meat-supply
2 Health Care Sector Demands Sustainable Meat and Poultry (Health Care without Harm): https://noharm-uscanada.
org/articles/press-release/us-canada/health-care-sector-demands-sustainable-meat-and-poultry
3 Extensive information for major buyers in the health-care sector interested in purchasing meat and poultry raised
without routine antibiotics is available via Health Care Without Harm: https://noharm-uscanada.org/purchasing
4 Antibiotic Use –Statement (Tyson Foods): http://www.tysonfoods.com/media/position-statements/antibiotic-use.aspx
5 Antibiotics Position Statement (Perdue Farms): https://www.perdue.com/perdue-way/no-antibiotics/
6 Antibiotics Stewardship Statement (Foster Farms): https://www.fosterfarms.com/because-we-care/antibioticstewardship/
7 Pilgrim’s Expects 25% of Its Chicken Will Be Antibiotic-Free by 2019 (Wall Street Journal): https://www.wsj.com/
articles/pilgrims-expects-25-of-its-chicken-will-be-antibiotic-free-by-2019-1429564675
8 Smithfield Foods Introduces Pure Farms™ Antibiotic-Free Product Line (Smithfield Foods): http://www.
smithfieldfoods.com/newsroom/press-releases-and-news/smithfield-foods-introduces-pure-farms8482-antibiotic-freeproduct-line
9 Cleaner Meat; Just months after Big Pork said it couldn’t be done, Tyson is raising up to a million pigs without
antibiotics (Quartz.com): https://qz.com/624270/just-months-after-big-pork-said-it-couldnt-be-done-tyson-is-raisingup-to-a-million-pigs-without-antibiotics/
10 Cargill eliminates 20% of shared-class antibiotics used for beef cattle (Cargill.com): https://www.cargill.com/news/
releases/2016/NA31934263.jsp
11 Certified Responsible Antibiotic Use (CRAU).Poultry that supports health from farm to fork (BattleSuperbugs.org):
http://battlesuperbugs.com/crau-standard
12 Animal Welfare Approved: https://animalwelfareapproved.us/
13 National Organic Program. United States Department of Agriculture (USDA.gov) https://www.ams.usda.gov/aboutams/programs-offices/national-organic-program
14 Certified Humane: http://certifiedhumane.org/
15 Official Listing of Approved USDA Process Verified Programs (USDA.org): https://www.ams.usda.gov/sites/default/
files/media/Official%20ListingPVP.pdf
16 Global Animal Partnership: http://www.globalanimalpartnership.org/
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Appendix E: Policies Leading to Reduced Antibiotic Use in Two
Countries
Denmark and the Netherlands are two European livestock-producing countries that have made significant
efforts to reduce antibiotic* use in the production of food animals. Both countries have robust and
profitable livestock sectors. They offer many lessons for the U.S. to draw upon in its own efforts to reduce
antibiotic use in food animal production.

Denmark
Denmark (along with Sweden and Norway) emerged as an early model for how the adoption of new
policies and practices could quickly and effectively reduce use of antibiotics in food animal production.

Establishment of DANMAP
The establishment of DANMAP, the Danish Integrated Antimicrobial Resistance Monitoring and Research
Programme, in 1995 provided a platform to document the effect of different actions taken. Figure 1, for
example, shows the impact of declining avoparcin use on the prevalence of avoparcin/vancomycin-resistant
Enterococcus faecium in Danish broilers.1
Figure 1. Avoparcin consumption and resistance (%) to avoparcin/vancomycin in E. faecium from broilers.

Similarly, Figure 2 shows that total antibiotic consumption in animals in Denmark, relative to 1994 levels,
dropped 43% by 2013 and 47% by 2015. Meanwhile, the number of pigs produced rose 15% from 1994 to
2015.25
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Figure 2. Antibiotic consumption and millions of pigs produced in Denmark, 1994-2015.

Data collection on veterinary use of antibiotics
As stated, DANMAP collects data on veterinary use of antibiotics. In Denmark, antibiotics are prescriptiononly drugs. By law, veterinarians are required to report each month on all prescriptions written and drugs
used for production animals to the VETSTAT database26; for most of them, the registration of data is
automatically linked to their writing of invoices. In addition to veterinary drug sales, data also are sent
electronically from pharmacies, private companies and feed mills to VETSTAT. For each prescribed item,
VETSTAT holds detailed information about its source and consumption, its date of sale, the prescribing
veterinarian, source ID (identity of the pharmacy, feed mill, or veterinarian practice reporting), package
identity code and amount, animal species, age-group, disease category and code for farm-identity (Central
Husbandry Register).27 At pharmacies, the electronic registration of sales data is linked to stock reports and
the billing process, ensuring the data are accurate with respect to the identity and amounts of antibiotics
listed there.
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Box A: Timeline of select Danish initiatives
Pre-1970s

All veterinary medical products are made available only by prescription.

1994

Central Husbandry Register is created to register and identify all herds.

1994/95

Prophylactic antibiotic use is prohibited.

1995

Veterinarian profits directly from sales of prescribed drugs are limited to 5-10% of income.

1995

DANMAP is created to research/monitor antibiotic use and resistance in humans, animals, food.

1995

Government bans growth promotion use of avoparcin.

1996

Pharmacies and the pharmaceutical industry are barred from increasing sales by offering economic
incentives to veterinarians or others.

1998

Government bans growth promotion use of virginiamycin.
The EU bans growth promotion uses of virginiamycin, bacitracin, tylosin, spiramycin.

2000

VETSTAT database established to record (by animal age group, herd and veterinarian) all antibiotics
prescribed for production animals.

2002

Fluoroquinolones intended for injection are restricted to use by veterinarians only.

2002

EU extends its earlier growth promotion ban to all antibiotics. Effective 2006.

2003

Mandatory susceptibility testing that documents the need for fluoroquinolones prior to their use in
production animals, and mandatory notification of authorities with that use as well.

2005
2007
2010

Action plan issued for reducing swine antibiotic use, including development of swine prudent use
guidelines, and outreach to veterinarians with a high prescription rate.
Action plan issued for also reducing antibiotics in cattle and poultry, including: (1) new treatment
guidelines; (2) biennial audit of veterinarians; and, (3) new oversight to ensure no financial conflicts
of interest between antibiotic makers and veterinarians.
“Yellow card” control of antibiotic use begins in pig production, imposing preventive measures in
the herds with highest consumption per pig.

2010

Use of cephalosporins in pig production is voluntarily ended.

2010

Evidence-based treatment guidelines are issued for swine veterinarians.

2010

Joint AMR action plan established by Ministries of Health, Food and Agriculture.

2010

One veterinarian/one farmer herd health agreements are mandated for swine and cattle,
with an emphasis on welfare and disease prevention not using antibiotics.

2010

Thresholds are established for antibiotic use, mortality and welfare parameters in swine, cattle.

2014

Differentiated taxes implemented on antibiotics for veterinary use.

2014

New and tighter rules on antibiotic treatment of groups of pigs.

2015

Action plan to control livestock-associated MRSA in pigs.

2016

“Yellow card” controls are differentiated to focus on prevention of fluoroquinolones and
cephalosporins use, and on limiting tetracycline use in pig production.
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Danish initiative
Over the years, many initiatives have been
undertaken in Denmark to reduce veterinary use of
antibiotics while maintaining a high level of animal
production and welfare. Close cooperation between
Denmark’s scientists and policymakers, as well as the
Danish livestock industry, allowed new initiatives to
be continuously developed and implemented that
further reduced antibiotic use.
Box A lists the initiatives by both governmental
interventions and voluntary actions taken by
industry. In brief, they include a ban on the use of
antibiotics that are critically important to human
medicine and measures to remove incentives for
farmers and veterinarians to use antibiotics as a
management tool. While some initiatives have
been evidence-based, others were grounded
more in common sense – sometimes necessary to
expeditiously address new problems. Though some
of the biggest changes in food animal production
took place two decades ago, the industries continue
to thrive. Denmark exports 60% of its poultry
meat28, and remains among the top three porkexporting nations in the European Union.29

inspections and increased veterinary supervision. A
pig producer may be required to reduce stocking
density, but only in the case of continued excessive
use of antibiotics.31 Using the yellow card system,
Denmark has lowered overall antibiotic use by
iteratively setting new thresholds, and then targeting
top antibiotic users.

The Netherlands
Before 2008, high antibiotic use in the Netherlands’
livestock sector persisted, despite an earlier end to
antibiotic use for growth promotion (See Figure 3)32.
Combined with public concern about the potential
for drug-resistant bacteria to spread from animals to
people, the persistently high usage led to additional
measures described in Box B, and instituted after
2008.33 These latter measures (See Box B) succeeded
in greatly reducing overall antibiotic use in the
sector (Figure 4).
Figure 3: Persistence of sales of antibiotics (in tons
of active substances) in the Netherlands
before and after a 2006 ban on antibiotic growth
promoters (AMGPs) (adapted)

Yellow card initiative
Denmark’s enhanced surveillance of both antibiotic
use and resistance in its pig production also
facilitated implementation of a warning (yellow
card) system. In 2005, large differences in antibiotic
use on farms were observed in VETSTAT. As a
result, authorities adopted treatment guidelines and
began auditing prescription patterns and usage.30
These measures eventually led to a yellow card
initiative targeting the pig producers with the
highest use of antibiotics. Pig producers found
to be using antibiotics above one or more of the
government-established thresholds within a ninemonth period face penalties that include limitations
on usage and/or storage of antibiotics, unannounced
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* Therapeutic use included antibiotics for treatment, control
and prevention until 2011, after which prevention uses
were no longer allowed.
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Because the Netherlands had successfully controlled
MRSA in hospitals through strict measures, reports
in 2005 of widespread livestock-associated MRSA
in pigs – and their potential transmission to livestock
workers – caused immediate concern.34 A multistakeholder task force was then formed to reduce
antibiotic use in food animal production.35 Officials
felt additional pressure after retail poultry was
discovered to be widely contaminated with bacteria
producing extended-spectrum beta-lactamase
(ESBL) enzyme. These bacteria were also potentially
linked to the death of a Dutch patient.36
The ESBL enzyme breaks down commonly used
antibiotics making the bacteria producing the
enzyme resistant to treatment by the affected
antibiotics.

Policies and framework
Setting targets. Using 2009 as a baseline, the
government set clear targets for reducing antibiotic
use in livestock production as a whole: 20% by
2011, and 50% by 2013. Both of these targets were
agreed to by the animal sector. In 2012, a reduction
target of 70% by 2015 was set by government decree
without agreement by the animal sector.37
Public-private partnership. The program in the
Netherlands has been set up as a public-private
partnership. Stakeholders in pig, broiler, veal
and cattle production, along with the Royal
Netherlands Veterinary Association (KNMvD), took
responsibility for putting in place effective measures,
while the national government provided facilitation,
legislation and inspection. Implementation plans
for meeting the above targets, for example, were
developed by the industry members.

Netherlands Veterinary Medicines Authority (SDa).
The SDa, the government and the public have
access only to the anonymized data. An independent
panel of experts from medicine, veterinary science,
epidemiology and pharmacy, convened by the SDa,
analyzes these data and prepares annual reports on
antibiotic use, the most recent being from 2016.38
Veterinary oversight. Farms must have only one
veterinarian per herd, who does periodic inspections
and who must prescribe any antibiotics administered.
Generally, the veterinarian inspects and assesses the
farm before doing so, except in very well-defined
instances. Farms also must have herd treatment and
health plans (mostly including resistance profiling
of the farm and tailored management practices) in
place. Antibiotics are tiered for farm use according
to their importance to human medicine. Farms
are allowed to treat up to 15% of their animals
using so-called first choice, non-critical antibiotics,
based on the yearly veterinary consultation and the
development of the aforementioned farm treatment
plan that includes treatment protocols for common
diseases on a particular farm. The second and third
tiers include certain critical drugs that may only be
administered by the consulting veterinarian.39 Thirdtier antibiotics (e.g. fluoroquinolones and 3rd and 4th
generation cephalosporins) also are only allowed if
susceptibility testing has demonstrated there to be no
available alternative antibiotic, and are typically not
used for herd or flock treatment. This tiering system
also applies to antibiotic use in pets.

Surveillance of antibiotic usage.Various livestock
sectors collect data on antibiotic use from 40,000
farms, anonymize it to protect the identity of
individuals, and then share it with the independent
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Benchmarking and Transparency. Critical to the program’s success has been establishing and clearly
communicating expectations. The goal of improved herd health is made clear, as are expected responsibilities
in antibiotic delivery and herd management. The independent panel of experts advising SDa proposes
veterinary benchmarks regarding the quantity of antibiotics to be used within each livestock (sub)sector. SDa
can then make comparisons between data collected from farms and veterinarians, although those data have
been anonymized. A 2014 SDA report, for example, contains the first analysis of prescription patterns by
Dutch veterinarians.40

Surveillance of antibiotic resistance. MARAN (the Monitoring of Antibiotic Resistance and Antibiotic
Usage in Animals in the Netherlands), the country’s chief program for monitoring antibiotic resistance in
animals, also tracks resistance trends in animals and retail meat.41 Monitoring programs across the country
randomly take samples from animals at slaughter; retail samples also are collected from chicken, pork, beef,
and turkey and other products, and reflect both domestic and imported products. Parallel to MARAN is
NethMap, which annually publishes yearly trend data for major pathogens affecting humans, based on robust
antibiotic susceptibility data collected from hospitals and held in the centralized repository, called ISIS-AR.
Resistance profiles of Enterococci, Salmonella spp., E. coli and Campylobacter spp. in food animals and retail
meat are presented in the NethMap-MARAN reports.

Reduction in antibiotic sales and antibiotic resistance
Figure 4 shows the rapid drop in antibiotic sales (the metric used to measure success) after various measures
were implemented starting in 2008. By 2012, total sales had dropped 49% relative from the 2009 baseline,
reaching the target originally set for 2013 a year early. Sales of 3rd and 4th generation cephalosporins,
antibiotics critically important to human health and also used in animals, dropped more than 90% over the
same period. By 2016, total sales had shown a further drop of more than 64%, relative to the 2009 baseline. 42
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Figure 4: Dutch sales of antibiotic agents, 1999 to 2016. By year and by 1,000s of kg. of active substances
sold [not including antibiotic growth promoters]43

Among the different animal species and four bacterial groups tested, antibiotic resistance has plateaued or
trended downward in recent years (with the exception of fluoroquinolone resistance in Campylobacter
spp.).44 These trends coincide with reduced antibiotic use in food animals. See Figures 5 and 6.
Figure 5: Trends in resistance (%) of C. jejuni bacteria isolate from broiler chickens and poultry meat in
the Netherlands
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Figure 6: Trends in resistance (%) of E. coli isolated from broilers, slaughter pigs, veal calves and dairy cattle
in the Netherlands. Similar favorable trends have been observed for Enterococci spp. and Salmonella spp. in
animal samples. (Adapted from MARAN 2016)45
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